Sugar check: new study tracks blood glucose in diabetic cancer patients during chemo
NCT ID NCT04315857
First seen Feb 02, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This study looked at 103 diabetic adults starting chemotherapy to see if a continuous glucose monitor (Freestyle Libre) could better track dangerous blood sugar highs and lows. Researchers wanted to find out if this device could help doctors manage diabetes more closely during cancer treatment. The study did not test a new treatment, but aimed to gather information for future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.